Revisiting the immunophenotype of nephrogenic adenoma

American Journal of Surgical Pathology

Volumn 33, Issue 11, 2009, Pages 1654-1658

  Fromont, Gaelle ^a   Barcat, Lucile ^a   Gaudin, Jean ^a   Irani, Jacques ^a  

^a UNIVERSITÉ DE POITIERS   (France)

Author keywords

AMACR; Immunohistochemistry; Nephrogenic adenoma; Renal tubule

Indexed keywords

BIOTIN; CYTOKERATIN 20; CYTOKERATIN 7; MUCIN 1; PROTEIN P63; TRANSCRIPTION FACTOR PAX2;

ADOLESCENT; ADULT; AGED; ARTICLE; BLADDER TUMOR; CELL DIFFERENTIATION; CHILD; CLINICAL ARTICLE; FEMALE; HUMAN; IMMUNOPHENOTYPING; KIDNEY ADENOMA; KIDNEY PARENCHYMA; KIDNEY TUBULE; MALE; PROSTATE CANCER; PROTEIN EXPRESSION; SCHOOL CHILD; TISSUE MICROARRAY; URETHRA TUMOR; UROTHELIUM;

ADENOMA; ADULT; AGED; CHILD; DIAGNOSIS, DIFFERENTIAL; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; IMMUNOPHENOTYPING; KIDNEY TUBULES; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; RACEMASES AND EPIMERASES; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL; UROLOGIC NEOPLASMS;

EID: 70350450353     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e3181b40061     Document Type: Article

References (16)

1. Allan CH, Epstein JI. Nephrogenic adenoma of the prostatic urethra. Am J Surg Pathol. 2001;25:802-808.
2. Cheng L, Cheville JC, Sebo TJ, et al. Atypical nephrogenic metaplasia of the urinary tract. Cancer. 2000;88:853-861.
3. Cossu-Rocca P, Contini M, Brunelli M, et al. S-100A1 is a reliable marker in distinguishing nephrogenic adenoma from prostatic adenocarcinoma. Am J Surg Pathol. 2009. [Epub ahead of print].
4. de Buys Roessingh AS, Laurini RN, Meyrat BJ. Nephrogenic adenoma of the urethra: an unusual cause of hematuria in a child. J Pediatr Surg. 2003;38:1-2.
5. Field G, Maurer S, Nagele U, et al. Immunoreactivity of p63 in monolayered and in vitro stratified human urothelial cell cultures compared with native urothelial tissue. Eur Urol. 2008;53: 1066-1073.
6. Gokaslan ST, Krueger JE, Albores-Saavedra J. Symptomatic nephrogenic metaplasia of ureter: a morphologic and immunohis-tochemical study of four cases. Mod Pathol. 2002;15:765-770.
7. Gupta A, Wang HL, Policarpio-Nicolas ML, et al. Expression of alpha-methylacyl-CoA racemase (p504S) in nephrogenic adenoma. Am J Surg Pathol. 2004;28:1224-1229.
8. Hansel DE, Nadasdy T, Epstein JI. Fibromyxoid nephrogenic adenoma: a newly recognized variant mimicking mucinous adeno-carcinoma. Am J Surg Pathol. 2007;31:1231-1237.
9. Hartmann A, Junker K, Dietmaier W, et al. Molecular evidence for progression of nephrogenic metaplasia of the urinary bladder to clear cell adenocarcinoma. Hum Pathol. 2006;37:117-120.
10. Mazal PR, Scauler R, Altenhuber-Muller R, et al. Derivation of nephrogenic adenomas from renal tubular cells in kidney-transplant recipients. N Engl J Med. 2002;347:653-659.
11. Meehan SM, Kraus MD, Kadambi PV, et al. Nephron segment localization of polyoma virus large T antigen in renal allograft. Hum Pathol. 2006;37:1400-1406.
12. Skinnider BF, Oliva E, Young RH, et al. Expression of alpha-methylacyl-CoA racemase (p504S) in nephrogenic adenoma: a significant immunohistochemical pitfall compounding the differential diagnosis with prostatic adenocarcinoma. Am J Surg Pathol. 2004;28:701-705.
13. Tong GX, Melamed J, Mansukhani M, et al. PAX2: a reliable marker for nephrogenic adenoma. Mod Pathol. 2006;19:356-363.
14. Tong GX, Weeden EM, Hamele-Bena D, et al. Expression of PAX8 in nephrogenic adenoma and clear cell adenocarcinoma of of the lower urinary tract: evidence of related histogenesis? Am J Surg Pathol. 2008;32:1380-1387.
15. Vosse BA, Seelentag W, Bachmann A, et al. Background staining of visualization systems in immunohistochemistry: comparison of the Avidin-Biotin Complex system and the EnVision system. Appl Immunohistochem Mol Morphol. 2007;15:103-107.
16. Xiao GQ, Burstein DE, Miller LK, et al. Nephrogenic adenoma: immunohistochemical evaluation for its etiology and differentiation from prostatic adenocarcinoma. Arch Pathol Lab Med. 2006; 130:805-810